Teva Still A 'Must-Own' Stock, Worth $86 By: Benzinga via Benzinga July 28, 2015 at 09:15 AM EDT In a report published Tuesday, Citi analyst Liav Abraham maintained a Buy rating on Teva Pharmaceutical Industries Ltd (ADR) (NYSE: ... Read More >> Related Stocks: Allergan Plc Teva Pharmaceutical Industries ADR